Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Bringing Faith and Science Together to Fight HIV in Africa

South Africa Time — Friday, February 01, 2019

Bringing Faith and Science Together to Fight HIV in Africa
- While most biomedical researchers want to make discoveries that will improve health for humankind, their intense, lab-based work — replete with cells ...

LEGACY - for researchers

Top stories of the last 30 days

NICE rejects long-acting HIV prevention treatment for NHS use

South Africa Time — Tuesday, September 22, 2026

Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...

Prior STI Diagnosis Linked to Greater PrEP Uptake

South Africa Time — Monday, September 21, 2026

PrEP can reduce the risk for HIV acquisition, but its use remains uneven among populations who may benefit from HIV prevention services. Researchers ... View article...

Is Aspen right to abandon lenacapavir for an unproven HIV prevention pill?

South Africa Time — Wednesday, September 23, 2026

... antiretroviral drug tenofovir. Apart from the tablets, ideally taken daily, HIV transmission could also be prevented by the correct use of condoms ... View article...

Most People With HIV Are Willing to Switch to Long-Acting Treatment

South Africa Time — Thursday, September 24, 2026

Researchers are exploring longer-acting antiretrovirals and broadly ... View article...

Structural basis of lenacapavir-induced HIV-1 capsid defects during virion maturation

South Africa Time — Tuesday, September 22, 2026

Long-acting lenacapavir (LEN) has emerged as a highly effective, potentially game-changing therapy for HIV treatment and prevention. View article...

Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV

South Africa Time — Thursday, September 24, 2026

People living with HIV face a quiet epidemic that has little to do with the virus itself. As antiretroviral therapy has transformed HIV into a ... View article...

None of the 12 clinics audited by the ECDC in Romania, Greece and Poland met the target ...

South Africa Time — Monday, September 28, 2026

A pilot audit of European HIV testing standards shows delays from a reactive test to diagnostic confirmation and major differences in rapid access ... View article...

Prevention, testing and treatment services for migrant populations in relation to HIV ...

South Africa Time — Monday, September 28, 2026

Migrant populations in the EU/EEA experience a disproportionately high burden of HIV , TB, and viral hepatitis. These infections – along with sexually ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Affordable HIV prevention injection to be offered in the MENA

South Africa Time — Tuesday, October 06, 2026

A twice-yearly generic HIV prevention drug will be offered for around $40 in several MENA countries, but many people still have no access. View article...

Long-Term Data Support Dolutegravir-, Fostemsavir-Based Regimens in MDR HIV-1

South Africa Time — Monday, October 05, 2026

In VIKING-3, the proportion of dolutegravir-treated patients who had an HIV -1 RNA level below 50 copies/mL was 69% at 24 weeks and 63% at 48 weeks. At ... View article...

Turkey targets LGBTQI+ medical organisations, isolating arrested people with HIV

South Africa Time — Tuesday, October 06, 2026

According to the Turkish Medical Association, restrictions on associations working on HIV can have a wider impact on public health. It also undermines ... View article...

Countries in Latin America and the Caribbean congratulated for eliminating new HIV ...

South Africa Time — Tuesday, October 06, 2026

... HIV , underscoring the Americas' growing leadership in ending new HIV infections among children. “Today we celebrate an achievement that reflects ... View article...

Adverse childhood experiences and HIV prevalence among adolescent girls and young ...

South Africa Time — Wednesday, October 07, 2026

HIV prevalence was 11.48%. While 38% of AGYW reported no ACEs, 62% experienced at least one. Cumulative ACEs were not significantly associated with ... View article...

About 40% of people living with HIV are in their 50s or older… people aging together ...

South Africa Time — Monday, October 05, 2026

According to the Korea Disease Control and Prevention Agency, consistent use of antiretroviral therapy suppresses the virus so that HIV does not ... View article...

The Future of HIV/AIDS in Iran by 2030: Using Trend Impact Analysis Ap

South Africa Time — Thursday, October 08, 2026

In Iran, fluctuations in the number of newly diagnosed HIV cases indicate an ongoing public health challenge and underscore the need to anticipate ... View article...

Researchers aim to control HIV without drugs

South Africa Time — Thursday, October 08, 2026

But antiretroviral drugs suppress HIV rather than eliminate it. Stop treatment, and the virus almost always returns. That has kept alive the question ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews